Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38023 |
FTISADTSK acetate
|
||
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1]. |